Private equity firm Hellman & Friedman agreed to buy MultiPlan Inc., a provider of health-care cost-management services.

Financial terms weren’t disclosed in a statement Thursday. The deal will be valued at about $7.5 billion, according to a person with knowledge of the matter who asked not to be identified because the information is private.

Starr Investment Holdings and Partners Group will retain minority investments in MultiPlan, according to the statement. As part of the transaction, GIC, Singapore’s sovereign wealth fund, and Leonard Green & Partners, will also invest along with Hellman & Friedman.

MultiPlan helps health-care companies manage costs and measure financial risks, working with almost 900,000 providers and handling about $40 million in claims each year, according to its website. Health care ompanies continue to receive strong buyer interest despite low expectations. Thoma Bravo LLC has closed a deal for MedeAnalytics  and Warburg Pincus acquired a majority stake in DocuTap. For more on M&A in the sector, see Health Care Data Providers Are Becoming Attractive Targets, Thanks to the Affordable Care Act.

The company was acquired by Starr and Partners Group in 2014 for about $4.4 billion, people with knowledge of the transaction said at the time. Starr, an investment firm, forms part of Starr Companies, which is headed by Maurice R. Greenberg, the former chairman of American International Group Inc.

Hellman, which was founded in 1984, is one of the world’s largest private equity firms having raised $10 billion for its eighth fund in 2014. The group invests in a variety of sectors including technology, media and telecommunications, finance, insurance and industrials, according to its website.

Barclays Plc, Goldman Sachs Group Inc. and Simpson Thacher & Bartlett are advising Hellman & Friedman. JP Morgan Chase & Co. and Kirkland & Ellis LLP are advising MultiPlan and the seller.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.